在以患者为中心的医疗家庭中,对患有NAFLD的患者进行他类药物处方模式
Allison L Cipriani1, Chelsey A Petz, Ellen M Nielsen
1Medical University of South Carolina, 171 Ashley Ave,Charleston, SC 29425.
The American journal of managed care
|August 24, 2023
概括
对非酒精性脂肪性肝病 (NAFLD) 患者的他类药物处方没有根据NAFLD状态而有所不同. 这突显了在这个高风险群体中改善心血管疾病预防的机会.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 主要护理医学 医疗保健
背景情况:
- 心血管疾病 (CVD) 是非酒精性脂肪肝疾病 (NAFLD) 患者的主要死亡原因.
- 类药物对于初级心血管疾病预防至关重要.
- 了解NAFLD患者的他类药物处方模式对于风险管理至关重要.
研究的目的:
- 研究诊断为NAFLD的初级保健患者的他类药物处方实践.
- 在这个队列中确定与他类药物处方相关的因素.
- 发现改善NAFLD患者心血管疾病风险降低的机会.
主要方法:
- 从2012年至2018年使用电子健康记录的回顾性队列研究.
- 包括652名肝硬化症患者,没有其他慢性肝病.
- 分析了临床因素,并发症和他类药物处方之间的关联.
主要成果:
- 56%的NAFLD患者接受了他类药物处方.
- 高龄,糖尿病,高血压和肥胖 (BMI ≥30 kg/m2) 与更高的他类药物处方几率有关.
- 氨基转移酶的升高与他类药物处方无关.
- 没有服用他类药物的近一半患者有治疗的迹象.
- 16%的人缺乏脂质检测结果.
结论:
- 在NAFLD和他类药物处方率之间没有发现直接关联.
- 在NAFLD患者的初级心血管疾病预防中存在显著的差距.
- 在这个人群中,有明显的机会改善他类药物的使用和心血管疾病风险管理.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
698
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
698
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Ultrasound II: Endoscopic Ultrasound and FibroScan
139
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
139
Chronic Pancreatitis II: Collaborative Care
113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
113
Atherosclerosis IV: Nursing Management
22
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
22
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9


